Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Work group: HI-TRON Mainz - Personalized Immunotherapies Area of research: Scientific
-
toxicity from advanced cell and immunotherapies in cancer. What you will get in return: Fantastic market leading Pension scheme Excellent employee health and wellbeing services including an Employee
-
fibroblasts for immunotherapy”(2023-2028). Expressions of interest should be sent to Dr. Tsoumakidou (tsoumakidou@fleming.gr ) and should contain a cover letter outlining the candidate’s interests and areas
-
in T cell-based immunotherapy (it might include CAR T cells), including studies on in vitro T cell-cancer cell interactions demonstrated by the first authorship in a peer-reviewed publication. While
-
are in the areas of extracellular vesicles & cell therapy, immunotherapy, nucleic acids therapeutics for brain cancer and neurodegenerative diseases. Duties and Responsibilities: Design and develop small
-
immunotherapy, or the roles of the microbiome in cancer susceptibility and progression. Candidates with other cancer related research interests may also be considered. Successful applicants will also be expected
-
people’s lives taking research a step beyond the lab. Research projects we are looking to pursue are in the areas of extracellular vesicles & cell therapy, immunotherapy, nucleic acids therapeutics
-
George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș | Romania | 23 days ago
job funded through the EU Research Framework Programme? Other EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Immunotherapy, translational
-
of new immune therapies for cancer patients. As a research technician, you work alongside PhD students, postdocs and other research technicians to improve immunotherapy against cancer. In
-
Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte